IDHIRA: a prospective, observational study on ivosidenib in patients with <i>IDH1</i> R132-mutated advanced cholangiocarcinoma.

ABSTRACT:

Clinical trial registration

www.clinicaltrials.gov identifier is NCT06607302.

SUBMITTER: Michl M 

PROVIDER: S-EPMC11988212 | biostudies-literature | 2025 Apr

REPOSITORIES: biostudies-literature